Studies in DS, sporadic, and autosomal‐dominant AD have shown elevated plasma GFAP levels in amyloid‐positive individuals prior to significant tau accumulation and cognitive impairment.10, 11, 12. This evidence concerns the gene GFAP and Dravet syndrome.